Corporate News     07-Oct-22
Indian Overseas Bank revises MCLR and RLLR
Indian Overseas Bank has revised the Marginal Cost of Funds based Lending Rate (MCLR) and Repo Linked Lending Rate (RLLR).

Tenor-wise MCLR with effect from 06 October 2022 as under:
Overnight - 7.20%
One month - 7.30%
Three month - 7.85%
Six month - 7.85%
One year - 7.90%
Two year - 7.95%
Three year - 7.95%

The Bank has revised the RLLR to 8.75% with effect from 10 October 2022.

Previous News
  Indian Overseas Bank spurts 1.87%, rises for third straight session
 ( Hot Pursuit - 01-Jul-25   13:05 )
  Indian Overseas Bank drops for fifth straight session
 ( Hot Pursuit - 16-Jun-25   13:35 )
  Indian Overseas Bank reduces external benchmark lending rate by 50 bps
 ( Corporate News - 11-Jun-25   18:59 )
  Indian Overseas Bank to convene AGM
 ( Corporate News - 07-Jun-25   12:39 )
  Indian Overseas Bank
 ( Results - Analysis 02-May-25   21:55 )
  Indian Overseas Bank consolidated net profit rises 34.74% in the March 2025 quarter
 ( Results - Announcements 02-May-25   14:45 )
  Indian Overseas Bank’s board to mull fund raising plan on 2nd May
 ( Hot Pursuit - 28-Apr-25   07:49 )
  Indian Overseas Bank schedules board meeting
 ( Corporate News - 25-Apr-25   11:01 )
  Market drift higher amid positive global cues; breadth strong
 ( Market Commentary - Mid-Session 20-Mar-25   09:33 )
  Stock Alert: Hyundai Motor India, Indian overseas Bank, NHPC, Can Fin Homes
 ( Market Commentary - Stock Alert 20-Mar-25   08:34 )
  Indian Overseas Bank schedules board meeting
 ( Corporate News - 07-Mar-25   14:56 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top